Adagene Inc
NASDAQ:ADAG
Adagene Inc
NASDAQ:ADAG
Price:
2.8 USD
7.9%
Updated:
Jun 3, 2024
Section:
Relative Value
The Relative Value of one
ADAG
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 2.8 USD,
Adagene Inc
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
ADAG Relative Value
HIDDEN
Valuation Multiples
Multiples Across Competitors
ADAG Competitors Multiples
Adagene Inc Competitors
Adagene Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
|
Adagene Inc
NASDAQ:ADAG
|
123.6m USD | 6.8 | -6.5 | -1.4 | -1.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
284.7B USD | 5.2 | 47.8 | 13.4 | 20.7 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
164.1B USD | 5.6 | 43.6 | 18.4 | 30.4 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
117.6B USD | 11.5 | 29.3 | 24.6 | 25.7 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
108B USD | 8.2 | 28 | 22.6 | 25.1 | |
| AU |
|
CSL Ltd
ASX:CSL
|
135.9B AUD | 6.4 | 36.6 | 22.1 | 27.4 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
80.1B USD | 2.9 | 165.5 | 8.4 | 11.1 | |
| US |
|
Moderna Inc
NASDAQ:MRNA
|
54.6B USD | 10.6 | -9.1 | -10.2 | -9.1 | |
| US |
|
Seagen Inc
NASDAQ:SGEN
|
43.1B USD | 18.8 | -57.5 | -61.9 | -55.8 | |
| US |
|
Biogen Inc
NASDAQ:BIIB
|
32.8B USD | 3.4 | 28.1 | 14.3 | 17.9 | |
| IE |
|
Horizon Therapeutics PLC
NASDAQ:HZNP
|
26.6B USD | 7.3 | 60.8 | 27.9 | 47 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
You don't have any saved screeners yet
